Faculty Opinions recommendation of Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.

2018 ◽  
Author(s):  
Boris Böll
Keyword(s):  
Randomised Trial ◽  
Final Analysis ◽  
Brentuximab Vedotin ◽  
Hodgkin's Lymphoma ◽  
Study Group ◽  
Line Treatment ◽  
Phase 2 ◽  
First Line ◽  
German Hodgkin Study Group ◽  
First Line Treatment

scholarly journals P5-5 Phase 2/3 study of bintrafusp alfa with gemcitabine plus cisplatin as first-line treatment of biliary tract cancer

2021 ◽  
Vol 32 ◽  
pp. S333
Author(s):  
Do-Youn Oh ◽  
Filippo de Braud ◽  
John Bridgewater ◽  
Junji Furuse ◽  
Chih-Hung Hsu ◽  
...  
Keyword(s):  
Biliary Tract ◽  
Biliary Tract Cancer ◽  
Line Treatment ◽  
Phase 2 ◽  
First Line ◽  
Tract Cancer ◽  
First Line Treatment
Sign in / Sign up

Export Citation Format

Share Document